Axxiem worked closely with Aerpio to help establish a new design for the overall website as well as graphics, including medical animations.
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases.
Aerpio's lead product candidate, AKB-9778, is a Tie2 activator developed for the treatment of diabetic eye disease.